Shah, Dimpy PSchool of Medicine |
|
| 6/2017 - Present | Assistant Professor | UT Health San Antonio, Department of Epidemiology & Biostatistics/Institute for Health Promotion Research, UT Health Cancer Center, San Antonio, TX |
| 5/2016 - Present | Adjunct Assistant Professor | The University of North Texas School of Public Health, Epidemiology, Fort Worth, TX |
| 3/2015 - Present | Adjunct Instructor | The University of Texas Health Science Center at Houston, Epidemiology, Human Genetics and Environmental Sciences, Houston, TX |
| Year | Degree | Discipline | Institution |
| 2014 | PhD | Epidemiology | The University of Texas at Houston School of Public Health Houston , TX |
| 2008 | MS | Epidemiology | Texas A&M Health Science Center School of Rural Public Health College Station , TX |
| 2005 | MD | Medicine | Seth G. S. Medical College K.E.M. Hospital Mumbai , India |
Journal Article |
| El Chaer F, Shah DP, Kmeid J, Ariza-Heredia E, Hosing CM, Mulanovich V, Chemaly RF. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes Cancer 2017 Jun;123(12):2329-2337. |
| Shah DP, Grimes C, Lai D, Hwang LY. Hepatitis C Incidence and Spontaneous Viral Clearance in a Cohort of Human Immunodeficiency Virus and Hepatitis B Virus Negative Drug Users Annals of Infectious Disease and Epidemiology 2017 Mar;2(2). |
| El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients Blood 2016 Dec;128(23):2624-2636. |
| El Chaer F, Mori N, Shah DP, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series Antiviral Research 2016 Nov;135:91-96. |
| El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia E, Mulanovich V, Gulbis A, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience Antiviral Research 2016 Oct;134:58-62. |
| Langman L, Nesher L, Shah DP, Azzi J, Shpall EJ, Rezvani K, Black JL, Chemaly RF. Challenges in determining genotypes for pharmacogenetics in allogeneic hematopoietic cell transplant recipients Journal of Molecular Diagnostics 2016 Sep;18(5):638-42. |
| Frenzel E, Chemaly RF, Ariza EH, Jiang Y, Shah DP, Thomas E, Graviss L, Raad I. Association of increased influenza vaccination in healthcare workers with a reduction in nosocomial influenza infections in cancer patients American Journal of Infection Control 2016 Sep;44(9):1016-21. |
| Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RFShah DP. Utility of the enzyme-linked immunospot interferon-y-release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients Journal of Infectious Diseases 2016 Jun;213(11):1701-7. |
| Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review Cancer Letters 2016 May;397(1):100-6. |
| Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza Heredia E, Hosing C, Mulanovich V, Chemaly RF. Outcomes of influenza infections in hematopoietic cell transplant recipients: Application of an Immunodeficiency Scoring Index Biology of Blood and Marrow Transplantation 2016 Mar;22(3):542-8. |
| Shah DP, Shah PK, Azzi JM, Chemaly RF. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review Cancer letters 2016 Jan;370(2):358-64. |
| Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji S, Maichailidis L, Marsh L, Chemaly RF. Influenza vaccination in patients with cancer: factors associated with vaccination practices for patients and their household members Infection Control & Hospital Epidemiology 2015 Oct;36(10):1239-41. |
| Avadhanula V, Chemaly RF, Shah DP, Ghantoji SS, Azzi JM, Aideyan L, Mei M, Piedra PA. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013 Journal of Infectious Diseases 2015 Feb;211(4):582-9. |
| Nesher L, Rolston K, Shah DP, Tarrand J, Mulanovich V, Ariza-Heredia E, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation Transplant Infectious Disease 2015 Feb;17(1):33-8. |
| Ariza-Heredia EJ, Gulbis A, Kebriae P, Stolar K, Shah DP, McConn K, Mulanovich V, Viola G, Chemaly RF. Vaccination guidelines after hematopoietic stem cell transplantation: Practitioners? knowledge, attitudes and gap between guidelines and clinical practice Transplant Infectious Disease 2014 Dec;16(6):878-86. |
| Chemaly RF, Shah DP, Boeckh M. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies Clinical Infectious Diseases Supplement 2014 Nov;59(5):S344-S351. |
| Wu Q, Xue XF, Shah DP, Zhao J, Hwang LY, Zhuang G. Knowledge, attitude, and practices regarding occupational HIV exposure and protection among health care workers in China: census survey in a rural area J Int Assoc Providers of AIDS Care (JIAPAC) 2014 Nov;15(5):363-9. |
| Nesher L, Chemaly RF, Shah DP, Mulanovich V, Hosing C, Rolston K. The utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center American Journal of Infection Control 2014 Oct;42(10):1084-8. |
| Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand J, LiPuma J, Guh A, MacCannell T, Raad I, Mulanovich V. Cluster and sporadic cases of Herbaspirillum spp. infections in patients with cancer Clinical Infectious Diseases 2014 Sep;60(1):48-54. |
| Chemaly RF, Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia E. Respiratory syncytial virus infections in children with cancer J Pediatric Hematology/Oncology 2014 Aug;36(6):e376-81. |
| Shah DP, Grimes CZ, Nguyen AT, Hwang LY. Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users American Journal of Public Health 2014 Jun;105(6):e36-43. |
| Shah DP, Ghantoji SS, Ariza E, Shah JN, El Taoum K, Shah PK, Nesher L, Hosing CM, Rondon GB, Champlin R, Chemaly RF. An Immunodeficiency Scoring Index to predict poor outcomes in hematopoietic cell transplant recipients with respiratory syncytial virus infections Blood 2014 May;123(21):3263-3268. |
| Kamath GK, Shah DP, Hwang LY. Immune response to hepatitis B vaccination in drug using population: a systematic review and meta-regression analysis Vaccine 2014 Apr;32(20):2265-74. |
| Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Jiang Y, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF. Impact of aerosolized ribavirin on mortality in 280 allogeneic hematopoietic stem cell transplant recipients with respiratory syncytial virus infections J Antimicrobial Chemotherapy 2013 Aug;68(8):1872-1880. |
| Grimes CZ, Hwang LY, Wei P, Shah DP, Volcik KA, Brown EL. Differentially regulated gene expression associated with hepatitis C virus clearance J General Virology 2013 Mar;94:534-42. |
| Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An adaptive randomized trial of intermittent dosing schedule of aerosolized ribavirin in cancer patients with respiratory syncytial virus infection J Infectious Disease 2012 Nov;206(9):1367-71. |
| Wu Q, Zhuang GH, Wang XL, Hou TJ, Shah DP, Wei XL, Wang LR, Zhang M. Comparison of long-term immunogenicity (23 years) of 10μg and 20μg doses of hepatitis B vaccine in healthy children Human Vaccines and Immunotherapeutics 2012 Aug;8(8):1071-6. |
Other |
| Shah DP, Munsell MF, Chemaly RF. Comparing Dosing Schedules of Aerosolized Ribavirin for preventing RSV-LRTI in Cancer Patients Journal of Infectious Diseases 2013 Jan;208(5):864-5. |
| Munsell MF, Shah DP, Chemaly RF. Reply to Fatkenheuer et al Journal of Infectious Diseases 2013 Jan;207(10):1622-3. |